drugset / Trial / NCT05291325

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy

NCT05291325

RandomizedParallel-groupSingle-blindDiagnostic

Summary

The clinical purpose of this study was to investigate whether the adjuvant application of linaclotide in bowel preparation for colonoscopy could improve the quality of bowel preparation or reduce the dosage of laxatives.

Timeline

Start
2022-05-25
Primary completion
2023-08-30
Completion
2024-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Linaclotide Peptide 1 unknown Oral
Subject polyethylene glycol Other / unclassified 1000 ml Oral
Subject polyethylene glycol Other / unclassified 1500 ml Oral

Indications

No indication recorded.